Clinical Trials · NCT00623974
Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 7
- Start date
- May 2008
- Locations
- 1 site, United States
- Primary endpoint
- Number of Patients With Success